Physician
Rosenthal, Marc
Rosenthal, Marc was paid $109K by Medicaid between Nov 2018 and Mar 2023, across 11 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 40% of everything it billed.
33Billing provider infoROSENTHAL, MARC
BURLINGTON, MA 01803
BURLINGTON, MA 01803
33aNPI1346225083assigned 12/14/2005
33bProvider typePediatrics Physician
28Total paid$109K
24GClaims1,124
24DCodes billed11
24AFirst – last monthNov 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#379 of 1,273
Median peer was paid$24K
This provider vs. median4.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23 | $1K | |
| 2019 | 13 | $1K | |
| 2020 | 17 | $2K | |
| 2021 | 144 | $18K | |
| 2022 | 884 | $80K | |
| 2023 | 43 | $6K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 40% | 174 | 171 | $44K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 423 | 413 | $36K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 17% | 233 | 228 | $18K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.6% | 127 | 124 | $4K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.8% | 14 | 14 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 38 | 38 | $2K |
| 87400 | 1.3% | 43 | 42 | $1K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 23 | 13 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 18 | 18 | $331.92 |
| 87807 | <1% | 15 | 15 | $255.97 | |
| 87081 | <1% | 16 | 16 | $145.92 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.